ORENCIA 250 mg powder for concentrate for solution for infusion

Company:
Bristol-Myers Squibb Pharma EEIG
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Abatacept
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/07/389/001

250 milligram(s)

L04AA24

Solution for infusion

EU/1/07/389/002

250 milligram(s)

L04AA24

Solution for infusion

EU/1/07/389/003

L04AA24

Solution for infusion